胰腺导管腺癌标准淋巴结清扫区域淋巴结病变:MRI能否准确识别淋巴结阳性患者?
本研究为单中心回顾性队列,纳入75例胰腺导管腺癌患者,评估MRI定性和定量特征诊断标准淋巴结清扫区域病理淋巴结的准确性。结果显示所有定性变量和影像医师判断均与病理淋巴结无关联,仅原发肿瘤最大径略有差异;观察者间一致性为中等(kappa=0.257)。结论认为MRI淋巴结形态特征和影像医师意见对诊断PDAC区域淋巴结病价值有限。
要点
- MRI淋巴结形态特征(如T2信号不均、圆形、边缘模糊、周围脂肪条索、扩散受限)与病理淋巴结无关联。
- 影像医师主观判断淋巴结阳性与病理结果无关联(p=0.520),观察者间一致性仅为中等(kappa=0.257)。
- 标准淋巴结清扫切除的淋巴结数量远多于MRI可检测数量(中位25 vs 5,p<0.001),提示需要改进诊断技术。
关键影像表现/征象
- 定性特征包括T2信号不均、圆形、边缘模糊、淋巴结周围脂肪条索、扩散受限程度大于脾脏,均与病理淋巴结无关联。
- 定量特征包括原发肿瘤大小、最大淋巴结短径和长径、区域淋巴结数目、绝对ADC值及淋巴结-脾ADC信号指数,除原发肿瘤最大径外均与病理淋巴结无关联。
- 病理淋巴结阳性患者原发肿瘤中位最大径略大于阴性患者(18 mm(10-42 mm) vs 16 mm(9-22 mm),p=0.027)。
- 影像医师判断淋巴结阳性与病理结果无关联(p=0.520),观察者间一致性中等(kappa=0.257)。
- 标准淋巴结清扫切除淋巴结中位25枚,MRI可检测中位5枚(p<0.001)。
诊断标准与关键数值
- 定性特征包括T2信号不均、圆形、边缘模糊、淋巴结周围脂肪条索、扩散受限大于脾脏,均未显示与病理淋巴结的关联。
- 定量特征包括原发肿瘤大小、最大淋巴结短径和长径、区域淋巴结数目、绝对ADC值及淋巴结-脾ADC信号指数,除原发肿瘤最大径外均未显示与病理淋巴结的关联。
- 影像医师主观判断淋巴结阳性与病理结果无关联(p=0.520),观察者间一致性kappa=0.257。
临床应用与阅片要点
- 日常阅片中不应仅依赖常规MRI淋巴结形态特征判断PDAC区域淋巴结转移。
- 影像医师主观判断淋巴结阳性可靠性有限,观察者间一致性仅为中等,需谨慎解读。
- MRI检测到的淋巴结数量远少于实际切除数量,报告时需注意假阴性可能。
局限性
- 单中心回顾性研究,样本量75例,可能存在选择偏倚。
- 病理淋巴结阳性比例高(85%,64/75),可能影响结果外推。
- 观察者间一致性仅为中等(kappa=0.257),提示主观评估可重复性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the accuracy of qualitative and quantitative MRI features for the diagnosis of pathologic regional lymph nodes at standard lymphadenectomy in patients with pancreatic ductal adenocarcinoma (PDAC).
METHODS: All adult patients with pancreatic MRI performed from 2011 to 2021 within 3 months of a pancreaticoduodenectomy were eligible for inclusion in this single-center retrospective cohort study. Regional nodes at standard lymphadenectomy were independently reviewed by two fellowship-trained abdominal radiologists for the following qualitative features: heterogeneous T2 signal, round shape, indistinct margin, peri-nodal fat stranding, and restricted diffusion greater than the spleen. Quantitative characteristics including primary tumor size, largest node short- and long-axes length, number of regional nodes, absolute apparent diffusion coefficient (ADC) values, and ADC node-to-spleen signal index were assessed. Analysis was at the patient-level with surgical pathology as the reference standard.
RESULTS: Of 75 patients, 85% (64/75) were positive for regional nodal disease on histopathology. None of the qualitative variables evaluated on MRI was associated with pathologic nodes. Median primary tumor maximum diameter was slightly larger for patients with pathologic nodes compared to those without (18 mm (10-42 mm) vs 16 mm (9-22 mm), p = 0.027). None of the other quantitative features was associated with pathologic nodes. Radiologist opinion was not associated with pathologic nodes (p = 0.520). Interobserver agreement was fair (kappa = 0.257).
CONCLUSIONS: Lymph node morphologic features and radiologist opinion using MRI are of limited value for diagnosing PDAC regional nodal disease. Improved diagnostic techniques are needed given the prognostic implications of pathologic lymph nodes in these patients.
KEY POINTS: • Multiple lymph node morphologic features routinely assessed on MRI for malignancies elsewhere in the body are likely not applicable when assessing for pancreatic ductal adenocarcinoma nodal disease. • Interobserver agreement for the presence or absence of pancreatic ductal adenocarcinoma lymph node morphologic features on MRI is fair (kappa = 0.257). • Many more lymph nodes are resected at PDAC standard lymphadenectomy than are detectable on MRI, median 25 vs 5 (p < 0.001), suggesting improved diagnostic techniques are needed to identify PDAC nodal disease.
引用
- Adham, Ferri, Lee, et al. Pancreatic ductal adenocarcinoma (PDAC) regional nodal disease at standard lymphadenectomy: is MRI accurate for identifying node-positive patients? Eur Radiol. 2023. PMID: 37004569. doi:10.1007/s00330-023-09597-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。